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httpAngiosarcoma at the site of nonfunctioning
arteriovenous ﬁstula in a kidney transplant recipient
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Mohamad F. Dawamneh, MD,d and Rola Rabah, MD,d Dhahran, Saudi Arabia
Angiosarcoma is a rare malignant neoplasm of the endothelial cells of blood vessels or lymphatics. We report a case of a
46-year-old male patient with a kidney transplant who developed epithelioid angiosarcoma at the site of a nonfunctioning
arteriovenous ﬁstula in the antecubital fossa 3 years after renal transplantation. The patient had skin, soft tissue, and bone
metastasis on presentation. He died of systemic metastasis with respiratory failure. (J Vasc Surg Cases 2016;2:53-5.)Angiosarcoma, a rare malignant neoplasm of the endo-
thelial cells of blood vessels or lymphatics, accounts
for <2% of all sarcomas with a predilection to soft tissues
and skin. Epithelioid angiosarcoma is a subtype of angiosar-
coma in which the malignant endothelial cells are epithe-
lioid in appearance. Renal transplant recipients may rarely
develop angiosarcoma at the site of arteriovenous (AV)
ﬁstulas.1-13 The survival of these patients is usually very
poor. We report a case of an epithelioid angiosarcoma at
the site of a nonfunctioning AV ﬁstula in a kidney trans-
plant recipient. Because of the rarity of the disease, clini-
cians should be aware of this malignant neoplasm as an
early diagnosis and intervention may affect the patient’s
outcome. A written consent was obtained from the patient
for photography and publication.
CASE REPORT
A 46-year-old man with a background history of hypertension
and atrial ﬁbrillation receiving chronic anticoagulation developed
end-stage renal disease of unknown cause and was started on hemo-
dialysis through a right-sidedbrachiocephalic AV ﬁstula. Three years
before presentation to our center, he underwent a living related kid-
ney transplantation from his son.He had beenmaintained onmyco-
phenolate mofetil, tacrolimus, and prednisone. In November 2013,
he presented to our hospital with pain and swelling of the right
upper extremity. On examination, there was a 3-  2-cm irregular,
rubbery, maroon lesion over the right antecubital fossa close tothe Oncology/Hematology Section,a Nephrology Section,b Derma-
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://dx.doi.org/10.1016/j.jvsc.2016.03.004the site of the AV anastomosis (Fig 1,A). Therewas no bruit or thrill
appreciated over the ﬁstula. There was swelling of the right forearm
extending from the elbow all the way down to the ﬁngers. He had
several bluish to black plaques and nodules over the right ﬁngers
and palm of variable sizes up to 1 cm in diameter (Fig 1, B). Plain
ﬁlms of the right upper extremity showed extensive lytic lesions
involving all the bones up to the distal humerus (Fig 2). Magnetic
resonance imaging scan showed the bone destruction at the area
of the main mass in the antecubital fossa and extending distally
down to the radius, ulna, and hand bones. The laboratory tests
revealed normal kidney allograft function with a serum creatinine
concentration of 1.0 mg/dL (0.4-1.4). Serum calcium concentra-
tion was 8.2 mg/dL (8.7-10.2), serum intact parathyroid hormone
level was 51.6 pg/mL (14-72), and parathyroid hormone-related
peptide level was 0.3 pmol/L (<2.0). The result of a serum test
for human herpesvirus 8 viral DNA by polymerase chain reaction
was negative.
A biopsy of one of the palmar lesions showed superﬁcial and
deep dermal proliferation of anastomosing vascular channels lined
by atypical cells with large hyperchromatic nuclei with frequent mi-
toses. The vascular channels were surrounded by abundant hemor-
rhage and extravasated red blood cells as well as hemosiderin
deposition. The inﬁltrating tumor cells showed areas of epithelioid
cells and other areas of spindle cells, some with open cytoplasmic
lumina. Perineural invasion was noted. The tumor extended to
the subcutaneous fat and fascia (Fig 3, A).
Biopsy from the AV ﬁstula site showed dilated thrombosed
venous blood vessels surrounded by cells similar to those seen in
the former biopsy with hemorrhage, necrosis, and vascular invasion
(Fig 3, B).
Immunohistochemical staining with CD31, AE2/AE3 kera-
tin, CK7, and vimentin was positive, whereas staining with
melan-A, S100, HMB-45, CD34, CK20, and actin was negative.
These pathologic changes conﬁrmed the diagnosis of epithelioid
angiosarcoma.
Staging workup with computed tomography showed metasta-
tic disease in both lungs represented by multiple lesions. Despite the
pulmonary involvement, the patient had no pulmonary symptoms.
After the diagnosis was made, the immunosuppressive regimen
was modiﬁed to sirolimus and prednisone, and he was started on
systemic paclitaxel. Restaging with computed tomography scan of
the chest after four cycles showed almost complete resolution of
the pulmonary lesions. Three of the hand lesions dried up and fell53
Fig 2. Plain ﬁlm of the right upper extremity showing extensive
lytic lesions.
Fig 1. A, Right antecubital fossa showing swelling with purple
discoloration of the skin at the site of the arteriovenous (AV)
ﬁstula. B, Multiple bluish fungating nodules and plaques on the
palmar side of the right hand and right-hand ﬁngers.
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antecubital fossa. Paclitaxel was replaced by sunitinib after ﬁve cycles
because of toxicity and lack of further response. The response of the
lung lesionswas excellent; however, he continued tohave severe pain
in the extremity with further weakness, rendering the limb
completely nonfunctional. Despite our attempt to control his pain
with local and systemic measures, it continued to be a major prob-
lem, leading to poor quality of life. In March 2014, he underwent
an above-elbow amputation for intractable pain. Unfortunately, 2
months after the amputation, he developed progression of his met-
astatic pulmonary disease and succumbed to respiratory failure 6
months after diagnosis.
DISCUSSION
Our patient developed angiosarcoma at the site of an
old, nonfunctioning AV ﬁstula and presented with systemic
metastatic disease involving the lungs, most likely as the
result of systemic hematogenous spread. The presentation
of the multiple scattered lesions in the skin, subcutaneous
tissue, and bones of the forearm most likely represented
hematogenous spread downstream from the AV ﬁstula site.
Angiosarcoma is a malignant neoplasm of the endothe-
lial cells of blood vessels or lymphatics accounting for <2%
of all sarcomas with a predilection to soft tissue or skin; 50%
of angiosarcomas arise in the head and neck region. AV ﬁs-
tulas are the sites of development of angiosarcomas in renal
transplant patients.1-13 Angiosarcoma also developed at the
site of AV ﬁstulas of hemodialysis patients who did notundergo renal transplantation.14,15 The malignant
neoplasm developed between 3 and 20 years after the cre-
ation of the ﬁstulas.1-15
Epithelioid angiosarcoma is a subtype of angiosarcoma
in which almost all malignant endothelial cells are epithe-
lioid in appearance. Fifty-four percent of the angiosarcomas
arising in dialysis AV ﬁstulas had the histologic features of
epithelioid angiosarcomas.1-8
On histopathologic evaluation, the tumor presents as
multinodular masses with cystic degeneration, hemorrhage,
and scarce or absent vascular spaces. The malignant epithe-
lioid endothelial cells are the hallmark of the epithelioid
angiosarcomas. Mitoses, nuclear atypia, and necrosis are
common features. The tumor cells are immunoreactive
for vimentin and for the vascular markers factor VIII,
CD31, and CD34 in 40% to 100% of cases. They are nega-
tive for S100 and melan-A. The histologic differential diag-
nosis includes malignant peripheral nerve sheath tumor,
epithelioid sarcoma, malignant melanoma, anaplastic large
cell lymphoma, and epithelioid hemangioendothelioma.16
The aggressive nature of the disease is reﬂected in the
high mortality rate in a period of 7 to 18 months. Systemic
chemotherapy is the only proven option that may prolong
survival in patients with metastatic angiosarcomas. These
tumors are found to be sensitive to taxanes in few retro-
spective case series.1,17
Several theories have explained the development of
angiosarcomas at the site of AV ﬁstulas. Proliferation of
Fig 3. A, Superﬁcial and deep dermal proliferation of anastomosing
vascular channels surrounded by abundant hemorrhage and
extravasated red blood cells as well as hemosiderin deposition
(hematoxylin and eosin 20). B, The inﬁltrating tumor cells
showing areas of solid epithelioid cells and other areas of spindle cells,
some with open cytoplasmic lumina (hematoxylin and eosin100).
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the shear forces and oscillatory ﬂow that upregulates the
vascular adhesion molecules, which stimulates endothelial
cell proliferation.18 Oscillatory ﬂows were also found to
trigger the overproduction of matrix metalloproteinase 9,
leading to vascular remodeling and increased metastatic
potential in soft tissue sarcomas.19
Immune suppression acts as an additive factor by sup-
pressing the immune surveillance, enhancing the action
of oncogenic viruses and facilitating production of vascular
endothelial growth factors that promote angiogenesis.20
Local ischemia at the site of an intact AV ﬁstula may
enhance the local toxic effect of immunosuppression. In
addition, increased venous pressure at the AV ﬁstula leads
to reduction of lymphatic drainage, which may lead to
impairment of local immune surveillance.6 Recently,
MYC gene ampliﬁcation was found in an angiosarcoma
arising from a clotted AV graft site.13
CONCLUSIONS
Angiosarcomas arising at AV ﬁstulas are very rare tumors
andmay present with unusual manifestation. Regular surveil-
lance of AV ﬁstulas in renal transplant recipients should bepart of the routine physical examination. Any suspicious
lesion at the site of AV ﬁstulas should alert the clinician to
perform skin biopsy tomake thediagnosis in a timelymanner.REFERENCES
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